Durham biopharma secures FDA greenlight for its antiviral smallpox therapy

Retrieved on: 2021-06-10 03:45:00

Tags for this article:

Health sciences

Medical specialties

Biomedical Advanced Research and Development Authority

Cowpox

Chimerix

Click the tags to see associated articles and topics

Durham biopharma secures FDA greenlight for its antiviral smallpox therapy. View article details on HISWAI: https://www.wraltechwire.com/2021/06/10/durham-biopharma-secures-fda-greenlight-for-its-antiviral-smallpox-therapy/

Excerpt

”Rewrite the Odds” is both a corporate slogan and a storyline for Durham biopharmaceutical company Chimerix, which is launching its first approved ...

Article found on: www.wraltechwire.com

View Original Article